Semax

Semax is a laboratory-produced peptide based on portions of adrenocorticotropic hormone (ACTH), with origins in Russian research. It has been investigated for possible effects on cognition, neuronal protection, and responses to stress, but the supplied guide does not establish clinical benefit.

ACTH participates in hormonal signaling associated with the body's response to stress. A peptide derived from part of ACTH should not automatically be assumed to reproduce the biological actions of the complete hormone.

The guide associates Semax with brain-derived neurotrophic factor (BDNF), presenting this signaling pathway as a possible contributor to neuronal maintenance and cognitive effects. It also proposes modulation of the hypothalamic–pituitary–adrenal (HPA) axis as a potential explanation for stress-related effects. The notes provide no study-level evidence establishing these mechanisms or their relevance to clinical outcomes.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 02 · Preclinical research

Laboratory or animal research exists. Findings do not transfer reliably to people.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide portrays Semax as a compound researched for mental performance, adaptation to stress, and recovery after neurological injury. It also characterizes tolerability favorably and suggests advantages over stimulant and anxiety-related medications. These statements reflect the guide's interpretation rather than conclusions supported by identifiable studies in the supplied material.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The notes do not identify study designs, populations, or results sufficient to determine whether the proposed benefits are reproducible in humans. BDNF is described as a potentially affected signaling factor, not an established direct binding target.

Safety data are limited, and the guide's reassuring language is insufficient to establish a comprehensive safety profile. The source mentions irritation of nasal tissues, headache, and heightened arousal; its assertions about absent dependence potential and comparative safety remain unsubstantiated in the supplied notes. This summary is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Semax peptide cognitive function”
• “Semax for neuroprotection and memory”
• “Semax clinical trial cognitive enhancement”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN